RU98103373A - PRODUCTION OF TRIAZOLEES BY ATTACHING METAL-ORGANIC COMPOUNDS TO KETONS, FINAL AND INTERMEDIATE PRODUCTS - Google Patents
PRODUCTION OF TRIAZOLEES BY ATTACHING METAL-ORGANIC COMPOUNDS TO KETONS, FINAL AND INTERMEDIATE PRODUCTSInfo
- Publication number
- RU98103373A RU98103373A RU98103373/04A RU98103373A RU98103373A RU 98103373 A RU98103373 A RU 98103373A RU 98103373/04 A RU98103373/04 A RU 98103373/04A RU 98103373 A RU98103373 A RU 98103373A RU 98103373 A RU98103373 A RU 98103373A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compound
- fluoropyrimidin
- paragraphs
- addition salt
- Prior art date
Links
- 150000002902 organometallic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 23
- 150000003839 salts Chemical class 0.000 claims 18
- 239000011780 sodium chloride Substances 0.000 claims 18
- 239000002253 acid Substances 0.000 claims 17
- -1 4-chloro-5-fluoropyrimidin-6-yl Chemical group 0.000 claims 9
- 229910052801 chlorine Inorganic materials 0.000 claims 8
- 239000000460 chlorine Substances 0.000 claims 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 7
- 229910052740 iodine Inorganic materials 0.000 claims 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 7
- 239000011630 iodine Substances 0.000 claims 7
- 239000003960 organic solvent Substances 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 239000002841 Lewis acid Substances 0.000 claims 4
- 125000001246 bromo group Chemical group Br* 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 150000007517 lewis acids Chemical class 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 238000005984 hydrogenation reaction Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 3
- 239000011701 zinc Substances 0.000 claims 3
- 229910052725 zinc Inorganic materials 0.000 claims 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N 2-Butanol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 2
- HNKWEUANACBPGC-UHFFFAOYSA-N 3-(2,6-dichloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC(Cl)=NC(Cl)=C1F HNKWEUANACBPGC-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- MIOPJNTWMNEORI-MHPPCMCBSA-M [(4R)-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonate Chemical compound C1C[C@]2(CS([O-])(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-MHPPCMCBSA-M 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000003840 hydrochlorides Chemical class 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 claims 2
- MFEDKMBNKNOUPA-UHFFFAOYSA-M (2-bromo-4,7-dimethyl-3-oxo-7-bicyclo[2.2.1]heptanyl)methanesulfonate Chemical compound C1CC2(C)C(=O)C(Br)C1C2(CS([O-])(=O)=O)C MFEDKMBNKNOUPA-UHFFFAOYSA-M 0.000 claims 1
- XUJHKPSBHDQIOD-UHFFFAOYSA-M (2-bromo-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonate Chemical compound C1CC2(CS([O-])(=O)=O)C(=O)C(Br)C1C2(C)C XUJHKPSBHDQIOD-UHFFFAOYSA-M 0.000 claims 1
- BQDLXFABVRRDFU-XXFAHNHDSA-N (2R,3S)-3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC(Cl)=C1F BQDLXFABVRRDFU-XXFAHNHDSA-N 0.000 claims 1
- GRYASYLFKKQPPF-UHFFFAOYSA-N 2-chloro-6-ethyl-5-fluoro-1H-pyrimidin-4-one Chemical compound CCC1=NC(Cl)=NC(O)=C1F GRYASYLFKKQPPF-UHFFFAOYSA-N 0.000 claims 1
- QGUBIXDOEDZGJI-UHFFFAOYSA-N 3-(2-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC(Cl)=NC=C1F QGUBIXDOEDZGJI-UHFFFAOYSA-N 0.000 claims 1
- BQDLXFABVRRDFU-UHFFFAOYSA-N 3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC=NC(Cl)=C1F BQDLXFABVRRDFU-UHFFFAOYSA-N 0.000 claims 1
- UNEWPWKCWOFZPU-UHFFFAOYSA-N 3-(6-chloropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=CC(Cl)=NC=N1 UNEWPWKCWOFZPU-UHFFFAOYSA-N 0.000 claims 1
- ZXMSBCQGASSUBH-UHFFFAOYSA-N 3-benzyl-6-(1-bromoethyl)-5-fluoropyrimidin-4-one Chemical compound O=C1C(F)=C(C(Br)C)N=CN1CC1=CC=CC=C1 ZXMSBCQGASSUBH-UHFFFAOYSA-N 0.000 claims 1
- BYPQMBZXTZGDEP-UHFFFAOYSA-N 3-benzyl-6-[3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidin-4-one Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C(=C(C1=O)F)N=CN1CC1=CC=CC=C1 BYPQMBZXTZGDEP-UHFFFAOYSA-N 0.000 claims 1
- AZJXRKANGIKJQD-UHFFFAOYSA-N 4-(1-bromoethyl)-2,6-dichloro-5-fluoropyrimidine Chemical compound CC(Br)C1=NC(Cl)=NC(Cl)=C1F AZJXRKANGIKJQD-UHFFFAOYSA-N 0.000 claims 1
- HNRVNZSHWCXVSQ-UHFFFAOYSA-N 4-(1-bromoethyl)-2-chloro-5-fluoropyrimidine Chemical compound CC(Br)C1=NC(Cl)=NC=C1F HNRVNZSHWCXVSQ-UHFFFAOYSA-N 0.000 claims 1
- BXIHJVDQQNZXBD-UHFFFAOYSA-N 4-(1-bromoethyl)-5-fluoropyrimidine Chemical compound CC(Br)C1=NC=NC=C1F BXIHJVDQQNZXBD-UHFFFAOYSA-N 0.000 claims 1
- AAESVRBYUDTWKH-UHFFFAOYSA-N 4-(1-bromoethyl)-6-chloro-5-fluoropyrimidine Chemical compound CC(Br)C1=NC=NC(Cl)=C1F AAESVRBYUDTWKH-UHFFFAOYSA-N 0.000 claims 1
- KSXLAAMIXVHNJJ-UHFFFAOYSA-N 4-(1-bromoethyl)-6-chloropyrimidine Chemical compound CC(Br)C1=CC(Cl)=NC=N1 KSXLAAMIXVHNJJ-UHFFFAOYSA-N 0.000 claims 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N Ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims 1
- VNDYJBBGRKZCSX-UHFFFAOYSA-L Zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims 1
- UAYWVJHJZHQCIE-UHFFFAOYSA-L Zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical class [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- MIOPJNTWMNEORI-UHFFFAOYSA-M camphorsulfonate anion Chemical compound C1CC2(CS([O-])(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-M 0.000 claims 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 229940102001 zinc bromide Drugs 0.000 claims 1
- 239000011592 zinc chloride Substances 0.000 claims 1
- 235000005074 zinc chloride Nutrition 0.000 claims 1
Claims (1)
или его аддитивной соли кислоты или основания,
где R представляет фенил, необязательно замещенный 1-3 заместителями, каждый из которых независимо выбран из галогена и трифторметила;
R1 представляет C1-C6-алкил;
"Het" является пиримидинилом, необязательно замещенным 1-3 заместителями, каждый из которых независимо выбран из C1-С4-алкила, С1-С4-алкокси, галогена, оксо, бензила и бензилокси,
включающий реакцию соединения формулы:
где R определен ранее для соединения формулы (I), с соединением формулы:
где R1 и "Het" определены ранее для соединения формулы (I), и Х представляет хлор, бром или иод, в присутствии цинка, иода и/или кислоты Льюиса и апротонного органического растворителя, с последующим необязательным превращением соединения формулы (I) в его аддитивную соль кислоты или основания.1. A method of obtaining a compound of the formula:
or an acid or base addition salt thereof,
where R represents phenyl, optionally substituted with 1-3 substituents, each of which is independently selected from halogen and trifluoromethyl;
R 1 represents C 1 -C 6 alkyl;
"Het" is pyrimidinyl optionally substituted with 1-3 substituents, each independently selected from C 1 -C 4 alkyl, C 1 -C 4 alkoxy, halogen, oxo, benzyl and benzyloxy,
comprising a reaction of a compound of the formula:
where R is previously defined for the compounds of formula (I), with the compound of the formula:
where R 1 and "Het" are previously defined for the compound of formula (I), and X is chloro, bromo or iodo, in the presence of zinc, iodine and / or Lewis acid and an aprotic organic solvent, followed by optional conversion of the compound of formula (I) to its acid or base addition salt thereof.
или его кислой аддитивной соли, где R и R1 определены ранее для соединения формулы (I) в п. 1, и R2 представляет Н или фтор; который включает стадии;
(а) реакции соединения формулы:
где R определен для соединения формулы (IV); с соединением формулы:
где Х - хлор, бром или иод, R1 и R2 определены ранее для соединения формулы (IV), и либо каждый из R3 и R4 независимо выбран из хлора или брома, либо один из R3 и R4 является хлором или бромом, а другой является Н, в присутствии цинка, иода и/или кислоты Льюиса и апротонного органического растворителя, с получением соединения формулы:
где R, R1, R2, R3 и R4 определены ранее для данной стадии (а);
(b) необязательного превращения соединения формулы (IА) в его кислую аддитивную соль;
(с) восстановления соединения формулы (IА) или его кислой аддитивной соли с получением соединения формулы (IV);
(d) необязательного превращения соединения формулы (IV) в его кислую аддитивную соль.19. A method of obtaining a compound of the formula:
or its acid addition salt, wherein R and R 1 are as previously defined for the compound of formula (I) in claim 1, and R 2 is H or fluoro; which includes stages;
(a) a reaction of a compound of the formula:
where R is defined for the compounds of formula (IV); with a compound of the formula:
where X is chlorine, bromine or iodine, R 1 and R 2 are previously defined for the compounds of formula (IV), and either each of R 3 and R 4 is independently selected from chlorine or bromine, or one of R 3 and R 4 is chlorine or bromine, and the other is H, in the presence of zinc, iodine and / or Lewis acid and an aprotic organic solvent, to obtain a compound of the formula:
where R, R 1 , R 2 , R 3 and R 4 are as previously defined for this step (a);
(b) optionally converting a compound of formula (IA) into its acid addition salt;
(c) reducing a compound of formula (IA) or an acid addition salt thereof to obtain a compound of formula (IV);
(d) optionally converting a compound of formula (IV) into its acid addition salt.
(i) R3 представляет хлор и R4 представляет Н;
(ii) R3 представляет Н и R4 представляет хлор;
или (iii) R3 и R4 оба представляют хлор.31. The method according to any one of paragraphs. 19-30 in which
(i) R 3 represents chlorine and R 4 represents H;
(ii) R 3 is H and R 4 is chloro;
or (iii) R 3 and R 4 both represent chlorine.
3-(4-хлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил)-1-(1H-1,2,4-триазол-1-ил)бутан-2-ол,
3-(2-хлop-5-фтopпиpимидин-6-ил)-2-(2,4-дифторфенил)-1-(1H-1,2,4-триазол-1-ил)бутaн-2-oл,
3-(2,4-дихлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил) -1-(1H-1,2,4-триазол-1-ил)бутан-2-ол или кислая аддитивная соль любого из них.35. The method according to any one of paragraphs.19-27, in which the compound of formula (IA) is:
3- (4-chloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan-2-ol,
3- (2-chlorop-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan-2-ol,
3- (2,4-dichloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan-2-ol or acid addition salt of any of them.
(i) (2R, 3S)-3-(4-хлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил) -1-(1H-1,2,4-триазол-1-ил)бутан-2-ол;
(ii) кислую аддитивную соль (2R,3S/2S,3R)- или (2R,3S)-3-(4-хлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил)-1-(1H-1,2,4-триазол-1-ил)бутан-2-ола и, предпочтительно, гидрохлоридную соль;
(iii) 3-(2,4-дихлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил) -1-(1H-1,2,4-триазол-1-ил)бутан-2-ол или же его (2R,3S/2S,3R)- или (2R,3S)-форму, или же кислую аддитивную соль любого из них;
(iv) 3-(2-хлор-5-фторпиримидин-6-ил)-2-(2,4-дифторфенил)-1-(1H-1, 2,4-триазол-1-ил)бутан-2-ол или же его (2R,3S/2S,3R)- или (2R,3S)-форму, или же кислую аддитивную соль любого из них; соль любого из них;
(v) 3-(1-бeнзил-5-фтopпиpимидин-6-oн-4-ил)-2-(2,4-дифторфенил)-1-(1Н-1,2,4-триазол-1-ил)бутан-2-ол, или же его (2R,3S/2S,3R)- или (2R,3S)-форму, или же кислую аддитивную соль любого из них; или
(vi) 3-(4-хлорпиримидин-6-ил)-2-(2,4-дифторфенил)-1-(1H-1,2,4-тpиaзoл-1-ил)бутaн-2-oл или же его (2R,3S/2S,3R)- или (2R,3S)-форму, или же кислую аддитивную соль любого из них;
38. Соединение формулы (III), определенной в п. 1, которое представляет собой
(i) 6-(1-бромэтил)-2,4-дихлор-5-фторпиримидин;
(ii) 4-(1-бромэтил)-6-хлорпиримидин;
(iii) 6-(1-бромэтил)-4-хлор-5-фторпиримидин;
(iv) 1-бензил-4-(1-бромэтил)-5-фторпиримидин-6-он;
(v) 6-(1-бромэтил)-2-хлор-5-фторпиримидин или
(vi) 4-(1-бромэтил)5-фторпиримидин.37. The compound of formula (I) as defined in claim 1, which is
(i) (2R, 3S) -3- (4-chloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1- il) butan-2-ol;
(ii) an acid addition salt of (2R, 3S / 2S, 3R) - or (2R, 3S) -3- (4-chloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1 - (1H-1,2,4-triazol-1-yl) butan-2-ol and, preferably, a hydrochloride salt;
(iii) 3- (2,4-Dichloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan- 2-ol or its (2R, 3S / 2S, 3R) - or (2R, 3S) -form, or an acid addition salt of any of them;
(iv) 3- (2-chloro-5-fluoropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1, 2,4-triazol-1-yl) butan-2- ol or its (2R, 3S / 2S, 3R) - or (2R, 3S) -form, or an acid addition salt of any of them; the salt of any of them;
(v) 3- (1-benzyl-5-fluoropyrimidin-6-one-4-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan-2-ol, or its (2R, 3S / 2S, 3R) - or (2R, 3S) -form, or the acid addition salt of any of them; or
(vi) 3- (4-chloropyrimidin-6-yl) -2- (2,4-difluorophenyl) -1- (1H-1,2,4-triazol-1-yl) butan-2-ol or its (2R, 3S / 2S, 3R) - or (2R, 3S) -form, or the acid addition salt of any of them;
38. The compound of formula (III) as defined in claim 1, which is
(i) 6- (1-bromoethyl) -2,4-dichloro-5-fluoropyrimidine;
(ii) 4- (1-bromoethyl) -6-chloropyrimidine;
(iii) 6- (1-bromoethyl) -4-chloro-5-fluoropyrimidine;
(iv) 1-benzyl-4- (1-bromoethyl) -5-fluoropyrimidin-6-one;
(v) 6- (1-bromoethyl) -2-chloro-5-fluoropyrimidine or
(vi) 4- (1-bromoethyl) 5-fluoropyrimidine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9516121.2 | 1995-08-05 | ||
GBGB9516121.2A GB9516121D0 (en) | 1995-08-05 | 1995-08-05 | Organometallic addition to ketones |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98103373A true RU98103373A (en) | 2000-01-27 |
RU2156760C2 RU2156760C2 (en) | 2000-09-27 |
Family
ID=10778850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98103373/04A RU2156760C2 (en) | 1995-08-05 | 1996-07-26 | Method of synthesis of triazoles, ultimate and intermediate compounds of method |
Country Status (32)
Country | Link |
---|---|
US (2) | US6586594B1 (en) |
EP (1) | EP0871625B1 (en) |
JP (3) | JP3211965B2 (en) |
KR (1) | KR100269048B1 (en) |
CN (1) | CN1076019C (en) |
AR (1) | AR003472A1 (en) |
AT (1) | ATE256679T1 (en) |
AU (1) | AU703337B2 (en) |
BR (1) | BR9609960A (en) |
CA (1) | CA2228655C (en) |
CZ (1) | CZ296975B6 (en) |
DE (1) | DE69631160T2 (en) |
DK (1) | DK0871625T3 (en) |
EG (1) | EG21200A (en) |
ES (1) | ES2210382T3 (en) |
GB (1) | GB9516121D0 (en) |
HK (1) | HK1014944A1 (en) |
HU (1) | HU224339B1 (en) |
IL (2) | IL122462A (en) |
IN (1) | IN190817B (en) |
MX (1) | MX9801025A (en) |
MY (1) | MY123062A (en) |
NO (1) | NO314938B1 (en) |
NZ (1) | NZ315651A (en) |
PE (1) | PE16897A1 (en) |
PL (1) | PL187227B1 (en) |
PT (1) | PT871625E (en) |
RU (1) | RU2156760C2 (en) |
TR (1) | TR199800170T1 (en) |
TW (1) | TW442480B (en) |
WO (1) | WO1997006160A1 (en) |
ZA (1) | ZA966587B (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7193083B2 (en) * | 1996-07-26 | 2007-03-20 | Pfizer, Inc. | Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
CN1678321A (en) | 2002-07-29 | 2005-10-05 | 里格尔药品股份有限公司 | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
EP1656372B1 (en) | 2003-07-30 | 2013-04-10 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
EP1786783A1 (en) * | 2004-09-01 | 2007-05-23 | Rigel Pharmaceuticals, Inc. | Synthesis of 2,4-pyrimidinediamine compounds |
CA2584295C (en) | 2004-11-24 | 2014-08-26 | Rigel Pharmaceuticals, Inc. | Spiro-2, 4-pyrimidinediamine compounds and their uses |
US20080194820A1 (en) * | 2004-12-14 | 2008-08-14 | Venkataraman Sundaram | Process For Preparing Voriconazole |
JP2008540436A (en) * | 2005-05-03 | 2008-11-20 | ライジェル ファーマシューティカルズ, インコーポレイテッド | JAK kinase inhibitors and uses thereof |
CA2640922A1 (en) | 2006-02-01 | 2007-11-22 | Medichem, S.A. | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
AR061889A1 (en) | 2006-07-13 | 2008-10-01 | Medichem Sa | IMPROVED PROCESS FOR THE PREPARATION OF VORICONAZOL |
CN1919846B (en) * | 2006-09-14 | 2013-01-02 | 大道隆达(北京)医药科技发展有限公司 | Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
KR100889937B1 (en) * | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | Process for preparing voriconazole |
GB2452049A (en) * | 2007-08-21 | 2009-02-25 | Alpharma Aps | Process for the preparation of voriconazole |
WO2009084029A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol |
CN101575330B (en) * | 2008-05-05 | 2012-10-31 | 丽珠医药集团股份有限公司 | Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof |
US20110312977A1 (en) * | 2009-02-17 | 2011-12-22 | Glenmark Generics Limited | Process for the preparation of voriconazole |
KR101109215B1 (en) | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | New intermediates of Voriconazole and preparation of Voriconazole using the same |
US8288394B2 (en) * | 2009-12-30 | 2012-10-16 | Medichem, S.A. | 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative |
KR100971371B1 (en) | 2010-02-04 | 2010-07-20 | 동국제약 주식회사 | Process for preparing voriconazole by using new intermediates |
EP2545039A1 (en) | 2010-03-10 | 2013-01-16 | Synthon BV | A process for making voriconazole |
CN102344441B (en) * | 2010-07-25 | 2015-05-06 | 浙江华海药业股份有限公司 | Technological improved method for preparing voriconazole intermediate |
CN101914091B (en) * | 2010-07-25 | 2015-05-27 | 浙江华海药业股份有限公司 | Method for preparing voriconazole intermediate |
US20140350252A1 (en) * | 2011-02-21 | 2014-11-27 | Nitin Maheshwari | Process for the preparation of voriconazole and intermediates thereof |
PL2720723T3 (en) | 2011-06-15 | 2018-10-31 | Synthon Bv | Stabilized voriconazole composition |
CN102516233B (en) * | 2011-12-09 | 2014-04-09 | 北京联本医药化学技术有限公司 | Method for producing voriconazole |
GR1007802B (en) * | 2012-01-31 | 2013-01-18 | Φαρματεν Αβεε, | Process for the preparation of bromopyrimidine derivative |
DK2906555T3 (en) * | 2012-10-15 | 2017-02-06 | Pfizer Ireland Pharmaceuticals | Process for the preparation of voriconazole and analogs thereof |
KR101435741B1 (en) | 2013-01-17 | 2014-08-29 | (주) 에프엔지리서치 | Novel voriconazole intermediate and synthesis of voriconazole |
CN105503834B (en) * | 2015-12-23 | 2021-03-05 | 浙江华海药业股份有限公司 | Synthetic method of voriconazole intermediate |
CN106432198B (en) * | 2016-09-08 | 2022-10-21 | 浙江华海药业股份有限公司 | Method for preparing voriconazole split intermediate |
CN106632267B (en) * | 2016-11-09 | 2019-02-22 | 中国科学院成都生物研究所 | A kind of synthetic method of voriconazole |
CN108276310A (en) * | 2017-01-06 | 2018-07-13 | 常州齐晖药业有限公司 | A kind of recovery method of voriconazole resolving agent (R) -10- camphorsulfonic acids |
CN108586433A (en) * | 2017-07-21 | 2018-09-28 | 齐鲁工业大学 | voriconazole hydrochloride with antibacterial activity |
CN109705102A (en) | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | The preparation method of voriconazole and its intermediate |
CN110305113A (en) * | 2019-07-05 | 2019-10-08 | 镇江市第四人民医院(镇江市妇幼保健院) | A kind of synthetic method of voriconazole impurity B |
CN112442017A (en) * | 2019-08-29 | 2021-03-05 | 珠海润都制药股份有限公司 | Method for preparing voriconazole racemate by adopting microchannel reactor |
CN110724130A (en) * | 2019-11-29 | 2020-01-24 | 怀化学院 | Synthetic method of voriconazole and intermediate thereof |
CN111440152B (en) * | 2020-05-18 | 2022-09-27 | 浙江诚意药业股份有限公司 | Preparation method of voriconazole |
CN112079819B (en) * | 2020-09-24 | 2022-06-17 | 南京易亨制药有限公司 | Improved voriconazole racemate preparation method |
CN112645935A (en) * | 2020-12-15 | 2021-04-13 | 植恩生物技术股份有限公司 | Preparation method of voriconazole key intermediate |
CN115724829A (en) * | 2022-12-23 | 2023-03-03 | 天津力生制药股份有限公司 | Liquid chromatography preparation method for separating impurities of fungal drug intermediate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819308D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
GB9002375D0 (en) | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
EP0665225B1 (en) * | 1994-02-01 | 1996-11-27 | Ube Industries, Ltd. | 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same |
-
1995
- 1995-08-05 GB GBGB9516121.2A patent/GB9516121D0/en active Pending
-
1996
- 1996-07-13 TW TW085108523A patent/TW442480B/en not_active IP Right Cessation
- 1996-07-26 TR TR1998/00170T patent/TR199800170T1/en unknown
- 1996-07-26 RU RU98103373/04A patent/RU2156760C2/en not_active IP Right Cessation
- 1996-07-26 CA CA002228655A patent/CA2228655C/en not_active Expired - Fee Related
- 1996-07-26 AT AT96927644T patent/ATE256679T1/en not_active IP Right Cessation
- 1996-07-26 PT PT96927644T patent/PT871625E/en unknown
- 1996-07-26 PL PL96324922A patent/PL187227B1/en not_active IP Right Cessation
- 1996-07-26 EP EP96927644A patent/EP0871625B1/en not_active Expired - Lifetime
- 1996-07-26 NZ NZ315651A patent/NZ315651A/en unknown
- 1996-07-26 DE DE69631160T patent/DE69631160T2/en not_active Expired - Fee Related
- 1996-07-26 ES ES96927644T patent/ES2210382T3/en not_active Expired - Lifetime
- 1996-07-26 IL IL12246296A patent/IL122462A/en not_active IP Right Cessation
- 1996-07-26 IL IL13152196A patent/IL131521A/en not_active IP Right Cessation
- 1996-07-26 WO PCT/EP1996/003376 patent/WO1997006160A1/en active IP Right Grant
- 1996-07-26 DK DK96927644T patent/DK0871625T3/en active
- 1996-07-26 HU HU9802766A patent/HU224339B1/en not_active IP Right Cessation
- 1996-07-26 US US09/011,346 patent/US6586594B1/en not_active Expired - Fee Related
- 1996-07-26 CN CN96196097A patent/CN1076019C/en not_active Expired - Fee Related
- 1996-07-26 JP JP50809797A patent/JP3211965B2/en not_active Expired - Lifetime
- 1996-07-26 CZ CZ0032798A patent/CZ296975B6/en not_active IP Right Cessation
- 1996-07-26 MX MX9801025A patent/MX9801025A/en not_active IP Right Cessation
- 1996-07-26 AU AU67403/96A patent/AU703337B2/en not_active Ceased
- 1996-07-26 BR BR9609960A patent/BR9609960A/en not_active IP Right Cessation
- 1996-07-26 KR KR1019980700842A patent/KR100269048B1/en not_active IP Right Cessation
- 1996-07-31 IN IN1707DE1996 patent/IN190817B/en unknown
- 1996-08-01 AR ARP960103831A patent/AR003472A1/en active IP Right Grant
- 1996-08-01 PE PE1996000578A patent/PE16897A1/en not_active Application Discontinuation
- 1996-08-02 ZA ZA9606587A patent/ZA966587B/en unknown
- 1996-08-03 MY MYPI96003196A patent/MY123062A/en unknown
- 1996-08-04 EG EG73196A patent/EG21200A/en active
-
1998
- 1998-02-02 NO NO19980441A patent/NO314938B1/en not_active IP Right Cessation
-
1999
- 1999-01-07 HK HK99100036A patent/HK1014944A1/en not_active IP Right Cessation
-
2000
- 2000-06-21 JP JP2000186089A patent/JP3224532B2/en not_active Expired - Fee Related
-
2001
- 2001-04-27 JP JP2001131297A patent/JP2001354670A/en active Pending
-
2003
- 2003-02-19 US US10/368,928 patent/US6946555B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98103373A (en) | PRODUCTION OF TRIAZOLEES BY ATTACHING METAL-ORGANIC COMPOUNDS TO KETONS, FINAL AND INTERMEDIATE PRODUCTS | |
DE60217126T2 (en) | PREPARATION OF AMINO-PRIMIDINE COMPOUNDS | |
RU2156760C2 (en) | Method of synthesis of triazoles, ultimate and intermediate compounds of method | |
KR840002827A (en) | Preparation of 2- [4-[(4,4-dialkyl-2,6-piperidindione-1-yl) butyl] piperazinyl] pyrimidines | |
RU2342383C2 (en) | IMIDAZOL-4-YLETHYNYL PYRIDINE DERIVATIVES, METHOD OF THEIR OBTAINING (VERSIONS) AND APPLICATION AS ANXIOLYTIC, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF DISORDERS MEDIATED BY RECEPTOR mGLuR5 | |
KR920008043A (en) | Hydroxymethyl (methylenecyclopentyl) purine and pyrimidine | |
KR850000430A (en) | Method for preparing 1,2,4-triazol-3-one antidepressant | |
KR870007140A (en) | Azolyl Derivatives Having Bactericidal Activity | |
KR900014358A (en) | 2- (1-piperazinyl) -4-phenylcycloalkanopyridine derivatives, methods for their preparation and pharmaceutical compositions containing them | |
US6624324B2 (en) | Process for producing optically active hemiesters | |
BE900714A (en) | 1,2,4-TRIAZOL-3-ONES ANTIDEPRESSIVE. | |
RU99115165A (en) | Method of producing thiazole derivatives | |
JP3805502B2 (en) | Method for producing pyrimidine derivatives | |
KR860000288A (en) | Method for preparing bis-triazole derivative | |
KR880007458A (en) | Lactam derivatives and preparation method thereof | |
EP0162265B1 (en) | The preparation of substituted gamma butyrolactones useful as intermediates for making fungicidal imidazoles and triazoles | |
RU2003117481A (en) | Pyrimidine derivatives | |
KR880011118A (en) | Insecticidal method using 2-phenyl imidazole derivative | |
DE05815687T1 (en) | PROCESS FOR PREPARING CITALOPRAM AND ENANTIOMERS | |
KR870001197A (en) | Geriatric psychiatric diazinylpiperidine derivatives of cyclic amides and imides | |
DE69619868T2 (en) | PIPERAZINYLALKYLTHIOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHOD FOR THE PRODUCTION THEREOF | |
CS274498B2 (en) | Fungicide and method of its active substances production | |
JP2762430B2 (en) | Preparation of aralkylaminopyrimidines | |
FI68616C (en) | PHARMACEUTICAL FORM OF PHARMACOLOGICAL PROPERTIES 1-ALKYL-2- (N-ALLYL-N- (2,6-DICHLOROPHENYL) -AMINO) -2-IMIDAZOLINE | |
WO2022130403A1 (en) | New quaternary ammonium salts for trifluoromethylation and process for the preparation thereof |